Second phase of operation will prioritize research projects with potential to help patients within the next six months
The COVID-19 High Performance Computing (HPC) Consortium, a unique public-private effort to make supercomputing power available to researchers working on projects related to COVID-19, today announced that it has entered into a new phase of operation focused on helping researchers to identify potential near term therapies for patients afflicted by the virus.
In this new phase, the Consortium plans to sharpen its focus on research projects that hold the potential to help improve patient outcomes within a six-month timeframe. This transition is due in part to the fact that there is now a greater volume of COVID-19 data available, creating more possibilities to potentially help patients than when the Consortium was launched in March 2020.
Created by IBM, The White House, and the US Department of Energy, the HPC Consortium brings together computing resources, software and services to help researchers everywhere better understand COVID-19, its treatments and potential cures. The Consortium has 43 members and has received more than 175 research proposals from researchers in more than 15 countries.
In its second phase of operation, the Consortium is particularly, though not exclusively, interested in projects focused on:
- Understanding and modeling patient response to the virus using large clinical datasets
- Learning and validating vaccine response models from multiple clinical trials
- Evaluating combination therapies using repurposed molecules
- Epidemiological models driven by large multi-modal datasets
"In just eight months, we've brought together an unprecedented scale of computing power to support COVID-19 research, and dozens of projects have already utilized these resources," said Dario Gil, Director of IBM Research. "At this stage, the Consortium partners believe that our combined computing resources now hold the potential to benefit patients in the near-term, as well as offering the potential for longer-term scientific breakthroughs."
"The Department of Energy is proud to play a significant role towards ending COVID-19," said Under Secretary for Science Paul Dabbar. "The second phase of the COVID-19 High Performance Computing Consortium can potentially provide tangible results to those affected by the virus, and we look forward to delivering these results to the American people."
To learn more about the new phase of operation, click here.
Since its launch, the HPC Consortium has attracted new members from industry, government and academia worldwide. As a result, the Consortium's computing capacity has almost doubled to 600 petaflops, from 330 petaflops in March. Together, the Consortium has helped support more than 90 research projects including:
- Understanding How Long Breath Droplets Linger: This research from a team at Utah State University simulated the dynamics of aerosols indoors, offering insight into how long breath droplets linger in the air. They found that droplets from breathing linger in the air much longer than previously thought, due to their small size when compared to droplets from coughing and sneezing.
- Understanding How COVID-19 Impacts Different Populations Research from a team at Iowa State University on so-called orphan genes could help better understand why African Americans are more vulnerable to COVID-19. They found that a little-studied gene, F8A2, is expressed more in African Americans than European Americans in every tissue studied. Since the gene is believed to be involved in endosome mobility, this could affect COVID-19 infection.
- Researching Drug Repurposing For Potential Treatments: A project from a team at Michigan State University screened data from about 1,600 FDA-approved drugs to see if there are possible combinations that could help treat COVID-19. They found promise in at least two FDA-approved drugs: proflavine, a disinfectant against many bacteria, and chloroxine, another antibacterial drug.
- Examining the Potential of Indian Medicinal Plants: Research from India's Novel Techsciences screened plant-derived natural compounds from 55 Indian medicinal plants to identify compounds with anti-viral properties that could be used against eight SARS-CoV-2 proteins. They found that phytochemicals from plants Withania somnifera and Azadirachta indica show multi-potency against different coronavirus proteins, meaning that they could help fight multi-drug resistance that may arise as the virus evolves
About the HPC Consortium
The COVID-19 High Performance Computing (HPC) Consortium, https://covid19-hpc-consortium.org, is a unique private-public effort spearheaded by the White House Office of Science and Technology Policy, the U.S. Department of Energy and IBM (NYSE: IBM) to bring together federal government, industry, and academic leaders who are volunteering free compute time and resources on their world-class machines. To learn more about the Consortium, or to request to join the Consortium, please click here.
More than ever, there is a demand for IT to deliver innovation. Your IBM i has been an essential part of your business operations for years. However, your organization may struggle to maintain the current system and implement new projects. The thousands of customers we've worked with and surveyed state that expectations regarding the digital footprint and vision of the company are not aligned with the current IT environment.
TRY the one package that solves all your document design and printing challenges on all your platforms. Produce bar code labels, electronic forms, ad hoc reports, and RFID tags – without programming! MarkMagic is the only document design and print solution that combines report writing, WYSIWYG label and forms design, and conditional printing in one integrated product. Make sure your data survives when catastrophe hits. Request your trial now! Request Now.
Forms of ransomware has been around for over 30 years, and with more and more organizations suffering attacks each year, it continues to endure. What has made ransomware such a durable threat and what is the best way to combat it? In order to prevent ransomware, organizations must first understand how it works.
Disaster protection is vital to every business. Yet, it often consists of patched together procedures that are prone to error. From automatic backups to data encryption to media management, Robot automates the routine (yet often complex) tasks of iSeries backup and recovery, saving you time and money and making the process safer and more reliable. Automate your backups with the Robot Backup and Recovery Solution. Key features include:
Business users want new applications now. Market and regulatory pressures require faster application updates and delivery into production. Your IBM i developers may be approaching retirement, and you see no sure way to fill their positions with experienced developers. In addition, you may be caught between maintaining your existing applications and the uncertainty of moving to something new.
IT managers hoping to find new IBM i talent are discovering that the pool of experienced RPG programmers and operators or administrators with intimate knowledge of the operating system and the applications that run on it is small. This begs the question: How will you manage the platform that supports such a big part of your business? This guide offers strategies and software suggestions to help you plan IT staffing and resources and smooth the transition after your AS/400 talent retires. Read on to learn:
LATEST COMMENTS
MC Press Online